Use apolipoprotein parameters and endpoints in drug development and approval processes

被引:6
作者
Alaupovic, P [1 ]
机构
[1] Oklahoma Med Res Fdn, Lipid & Lipoprot Lab, Oklahoma City, OK 73104 USA
关键词
D O I
10.1016/S0002-9149(98)00260-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:40F / 47F
页数:8
相关论文
共 113 条
  • [61] APOLIPOPROTEINS AND CORONARY-ARTERY DISEASE
    KOTTKE, BA
    ZINSMEISTER, AR
    HOLMES, DR
    KNELLER, RW
    HALLAWAY, BJ
    MAO, SJT
    [J]. MAYO CLINIC PROCEEDINGS, 1986, 61 (05) : 313 - 320
  • [62] CLINICAL-SIGNIFICANCE OF MEASUREMENTS OF SERUM APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-A-II AND APOLIPOPROTEIN-B IN HYPERTRIGLYCERIDEMIC MALE-PATIENTS WITH AND WITHOUT CORONARY-ARTERY DISEASE
    KUKITA, H
    HAMADA, M
    HIWADA, K
    KOKUBU, T
    [J]. ATHEROSCLEROSIS, 1985, 55 (02) : 143 - 149
  • [63] SERUM APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-A-II AND APOLIPOPROTEIN-B LEVELS AND THEIR DISCRIMINATIVE VALUES IN RELATIVES OF PATIENTS WITH CORONARY-ARTERY DISEASE
    KUKITA, H
    HIWADA, K
    KOKUBU, T
    [J]. ATHEROSCLEROSIS, 1984, 51 (2-3) : 261 - 267
  • [64] PREVALENCE OF HYPERAPOBETALIPOPROTEINEMIA AND OTHER LIPOPROTEIN PHENOTYPES IN MEN (AGED LESS-THAN-OR-EQUAL-TO-50 YEARS) AND WOMEN (LESS-THAN-OR-EQUAL-TO-60 YEARS) WITH CORONARY-ARTERY DISEASE
    KWITEROVICH, PO
    CORESH, J
    BACHORIK, PS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (08) : 631 - 639
  • [65] COMPARISON OF THE PLASMA-LEVELS OF APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I, AND OTHER RISK-FACTORS IN MEN AND WOMEN WITH PREMATURE CORONARY-ARTERY DISEASE
    KWITEROVICH, PO
    CORESH, J
    SMITH, HH
    BACHORIK, PS
    DERBY, CA
    PEARSON, TA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (12) : 1015 - 1021
  • [66] PREVALENCE OF DYSLIPIDEMIC PHENOTYPES IN ISCHEMIC-HEART-DISEASE (PROSPECTIVE RESULTS FROM THE QUEBEC CARDIOVASCULAR STUDY)
    LAMARCHE, B
    DESPRES, JP
    MOORJANI, S
    CANTIN, B
    DAGENAIS, GR
    LUPIEN, PJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (17) : 1189 - 1195
  • [67] LEVELS OF SERUM-LIPIDS, APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B AND PSEUDOCHOLINESTERASE ACTIVITY AND THEIR DISCRIMINATIVE VALUES IN PATIENTS WITH CORONARY-BYPASS OPERATION
    LEHTONEN, A
    MARNIEMI, J
    INBERG, M
    MAATELA, J
    ALANEN, E
    NIITTYMAKI, K
    [J]. ATHEROSCLEROSIS, 1986, 59 (02) : 215 - 221
  • [68] CHARACTERIZATION OF A MONOCLONAL-ANTIBODY THAT BINDS TO APOLIPOPROTEIN-E AND TO LIPOPROTEIN OF HUMAN-PLASMA CONTAINING APO-E - APPLICATIONS TO ELISA QUANTIFICATION OF PLASMA APO-E
    LEROY, A
    VUDAC, N
    KOFFIGAN, M
    CLAVEY, V
    FRUCHART, JC
    [J]. JOURNAL OF IMMUNOASSAY, 1988, 9 (3-4): : 309 - 334
  • [69] LIPID, LIPOPROTEIN AND APOLIPOPROTEIN DISTRIBUTIONS IN AN ELDERLY NEW-ZEALAND POPULATION
    LINTOTT, CJ
    HANGER, HC
    SCOTT, RS
    SAINSBURY, R
    FRAMPTON, C
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (02): : 162 - 167
  • [70] PLASMA-LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN TAIPEI AND FRAMINGHAM
    LYU, LC
    SHIEH, MJ
    ORDOVAS, JM
    LICHTENSTEIN, AH
    WILSON, PWF
    SCHAEFER, EJ
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10): : 1429 - 1440